Search

everythinglearnresearchcommunity

for

Search:↓

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Topical minoxidil helps hair regrowth in over 50% of men and women.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Trichoscopy is better than trichogram for diagnosing female hair loss.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Hair loss in postmenopausal woman caused by ovarian issue.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

A deep learning model accurately predicts male hair loss types using scalp images.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Both genetic and lifestyle factors significantly affect female hair loss.

Apoptosis contributes to hair loss in androgenetic alopecia.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

Early transplantation helps avoid embarrassment and allows relaxed transplant sessions, but be cautious with young patients with thinning hair.

BeauTop improves hair growth in androgenetic alopecia patients.

Carlos Oscar Uebel developed a hair transplant method that looks natural, has low risk, and shows full growth in 6-12 months.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.